| x | ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|---|--------------------------------------------------------------------------------------|

|  ̈ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|--------|------------------------------------------------------------------------------------------|

| Delaware                                                      |   | 20-8767223                        |
|---------------------------------------------------------------|--------|-----------------------------------|
| (State or other jurisdiction ofincorporation or organization) |   | (IRS Employer Identification No.) |
|                                                          |   |                              |
| 25/F New World Center, No. 6009                               |   |                              |
| Yitian Road, Futian District,                            |   |                              |
| Shenzhen,                                                     |   |                              |
| People’s Republic of China                              |   | 518026                            |
|                                                          |   |                              |
| (Address of principal executiveoffices)                       |   | (Zip Code)                        |

| Title of each class registered: |   | Name of each exchange on whichregistered: |
|---------------------------------|--------|-------------------------------------------|
| None                            |   | None                                      |

----

| Large accelerated filer     ̈ | Accelerated filer   ̈    |
|--------------------------------------------------|-----------------------------------|
|                                             |                              |
| Non-accelerated filer     ̈   | Smaller reporting company  x |

----

| ExhibitNumber |   | Description                                                                                                                                                 |
|---------------|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 3.1           |   | Articles of Incorporation *                                                                                                                                 |
| 3.2           |   | Bylaws *                                                                                                                                                    |
| 3.3           |   | Specimen of Common Stock Certificate**                                                                                                                      |
| 10.1          |   | Share Exchange Agreement, dated August 12, 2010, by and among Top Flight, Global Pharma BVI, and Mei Li Sai**                                               |
| 10.2          |   | Loan Contract, dated December 23, 2009, by and between Yaoyuan and Qilu Bank**                                                                              |
| 10.3          |   | Loan Contract, dated March 22, 2010, by and between Yaoyuan and Qilu Bank**                                                                                 |
| 10.4          |   | Lease Contract, by and between Xuelingxian and Bozhou Fengyi Chinese Medicine Development and Research Institute **                                         |
| 10.5          |   | Lease Agreement, dated January 1, 2010, by and between Meng Wang Village Committee of Dayang Town of Qiaocheng District in Bozhou City and Xuelingxian***** |

----

| 10.6   |   | Supplementary Lease Agreement, dated June 23, 2010, by and between Meng Wang Village Committee of Dayang Town of Qiaocheng District in Bozhou City and Xuelingxian**                                                          |
|--------|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 10.7   |   | Lease Agreement, dated July 2, 2010, by and between Meng Wang Village Committee of Dayang Town of Qiaocheng District in Bozhou City and Xuelingxian*****                                                                      |
| 10.8   |   | Lease Contract, dated May 27, 2009, by and between Yaoyuan and General Tobacco Group Co., Ltd. *****                                                                                                                          |
| 10.9   |   | Lease Contract, dated March 1, 2010, by and between Yaoyuan and General Tobacco Group Co., Ltd.**                                                                                                                             |
| 10.10  |   | Lease Contract, dated June 19, 2010, by and between Yaoyuan and General Tobacco Group Co., Ltd. *****                                                                                                                         |
| 10.11  |   | Lease Contract, dated July 1, 2010, by and between Yaoyuan and General Tobacco Group Co., Ltd. *****                                                                                                                          |
| 10.12  |   | Lease Contract, dated October 25, 2008, by and between XuShujun and Tonghua Tongdetang Pharmaceutical Company.**                                                                                                         |
| 10.13  |   | Lease Agreement, dated November 28, 2010, by and between XiuyingHou and Tongdetang*****                                                                                                                                       |
| 10.14  |   | Lease Contract, dated November 17, 2010, by and between Xiangqing Zhao, Qiudong Yu and Global Pharma BVI*****                                                                                                                 |
| 10.15  |   | Drug Purchase and Sales Contract, dated January 9, 2009, by and between Changchun YongxinDirui Drug Co., Ltd. and Tongdetang**                                                                                                |
| 10.16  |   | Drug Purchase and Sales Agreement, dated January 16, 2009, by and between Changchun Changheng Pharmaceutical Co., Ltd. and Tongdetang**                                                                                       |
| 10.17  |   | Distribution Agency Agreement, dated February 1, 2009, by and between Bozhou City ZhongzhengSliced Chinese Crude Drugs Co., Ltd and Xuelingxian**                                                                             |
| 10.18  |   | Distribution Agency Agreement, dated February 11, 2010, by and between Bozhou City Zhongzheng Sliced Chinese Crude Drugs Co., Ltd and Xuelingxian*****                                                                        |
| 10.18A |   | Distribution Agency Agreement, dated January 15, 2011, by and between Bozhou City Zhongzheng Sliced Chinese Crude Drugs Co., Ltd and Xuelingxian*****                                                                         |
| 10.19  |   | Sales Agreement, dated January 20, 2009, by and between Anhui Province Suzhou City Sliced Chinese Crude Drugs Co., Ltd and Xuelingxian**                                                                                      |
| 10.20  |   | Distribution Agreement, dated March 15, 2009, by and between Anhui Province Suzhou City Traditional Chinese Medicine Co., Ltd., and Xuelingxian**                                                                             |
| 10.21  |   | Distribution Agreement, dated January 1, 2010 by and between Xiuzheng Pharmaceutical Group Marketing Co., Ltd., and Yaoyuan*****                                                                                              |
| 10.21A |   | Distribution Agreement, dated January 1, 2011 by and between Xiuzheng Pharmaceutical Group Marketing Co., Ltd., and Yaoyuan*****                                                                                              |
| 10.22  |   | Distribution Agreement, dated January 1, 2010 by and between Hainan Lingkang Pharmaceutical Co., Ltd., and Yaoyuan*****                                                                                                       |
| 10.22A |   | Distribution Agreement, dated January 1, 2011 by and between Hainan Lingkang Pharmaceutical Co., Ltd., and Yaoyuan*****                                                                                                       |
| 10.23  |   | Trademark Use Agreement, dated  January 1, 2009, by and between Jingsheng Wang and Xuelingxian; Trademark Use Agreement, dated March 28, 2009, by and between Jingsheng Wang and Binomial Biopharm Group Limited.** |
| 10.24  |   | Trademark License Declaration, dated April 7, 2010, by Yanliang Song**                                                                                                                                                        |
| 10.25  |   | Employment Agreement, dated August 6, 2010, by and between Yunlu Yin and Top Flight**                                                                                                                                         |
| 10.26  |   | Employment Agreement, dated August 6, 2010, by and between An Fu and Top Flight**                                                                                                                                             |
| 10.27  |   | Employment Agreement, dated August 6, 2010, by and between Dan Li and Top Flight**                                                                                                                                            |
| 10.28  |   | Earn-in Agreement*****                                                                                                                                                                                                        |
| 10.28A |   | Agreement to Amend Earn-In Agreement****                                                                                                                                                                                      |
| 10.29  |   | Equity Transfer Agreement of Shandong Global Pharm Company*****                                                                                                                                                               |

----

| 10.30 |   | Equity Transfer Agreement of Tonghua Tongdetang Pharmaceutical Company*****                                                                             |
|-------|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------|
| 10.31 |   | Equity Transfer Agreement of Anhui Xuelingxian Pharmaceutical Company*****                                                                              |
| 10.32 |   | Loan Contract, dated May 7, 2010, by and between Xueling Xian and Construction Bank of China at Bozhou Branch*****                                      |
| 11.1  |   | Code of Business Conduct and Ethics*****                                                                                                                |
| 16.1  |   | Letter from the Company to GBH CPAs, CPA, dated as August 11, 2010**                                                                                    |
| 16.2  |   | Letter from GBH CPAs to the SEC, dated August 12, 2010**                                                                                                |
| 16.3  |   | Consent Letter of Acquavella, Chiarelli, Shuster, Berkower& Co., LLP dated August 25, 2010**                                                        |
| 21.1  |   | List of Subsidiaries**                                                                                                                                  |
| 31.1  |   | Certification by the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002                                                  |
| 31.2  |   | Certification by the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002                                                  |
| 32.1  |   | Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Chief Executive Officer). ***** |
| 32.2  |   | Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Chief Financial Officer). ***** |
| 99.1  |   | Audit Committee Charter***                                                                                                                              |
| 99.2  |   | Compensation Committee Charter***                                                                                                                       |
| 99.3  |   | Nominating Committee Charter***                                                                                                                         |

----

|                |   | GLOBAL PHARM HOLDINGS GROUP, INC.                                   |   |
|---------------------|--------|---------------------------------------------------------------------|--------|
|                |   |                                                                |   |
| Date: July 21, 2011 |   | /s/ Yunlu Yin                                                       |   |
|                |   | Yunlu Yin                                                           |   |
|                |   | Chief Executive Officer and President (Principal Executive Officer) |   |
|                |   |                                                                |   |
| Date: July 21, 2011 |   | /s/ An Fu                                                           |   |
|                |   | An Fu                                                               |   |
|                |   | Chief Financial Officer                                             |   |
|                |   |  (Principal Financial Officer)                                 |   |

----